HK1125968A1 - - Google Patents

Info

Publication number
HK1125968A1
HK1125968A1 HK09103920.0A HK09103920A HK1125968A1 HK 1125968 A1 HK1125968 A1 HK 1125968A1 HK 09103920 A HK09103920 A HK 09103920A HK 1125968 A1 HK1125968 A1 HK 1125968A1
Authority
HK
Hong Kong
Application number
HK09103920.0A
Inventor
Haruo Sugiyama
Original Assignee
Int Inst Cancer Immunology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Inst Cancer Immunology Inc filed Critical Int Inst Cancer Immunology Inc
Publication of HK1125968A1 publication Critical patent/HK1125968A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/461Cellular immunotherapy characterised by the cell type used
    • A61K39/4611T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/464Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643Vertebrate antigens
    • A61K39/4644Cancer antigens
    • A61K39/464452Transcription factors, e.g. SOX or c-MYC
    • A61K39/464453Wilms tumor 1 [WT1]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
HK09103920.0A 2006-02-22 2009-04-28 HK1125968A1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006045287 2006-02-22
PCT/JP2007/053176 WO2007097358A1 (ja) 2006-02-22 2007-02-21 Hla-a*3303拘束性wt1ペプチド、およびそれを含む医薬組成物

Publications (1)

Publication Number Publication Date
HK1125968A1 true HK1125968A1 (xx) 2009-08-21

Family

ID=38437397

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09103920.0A HK1125968A1 (xx) 2006-02-22 2009-04-28

Country Status (23)

Country Link
US (5) US8759483B2 (xx)
EP (3) EP1988163B1 (xx)
JP (1) JP5393144B2 (xx)
KR (1) KR101391561B1 (xx)
CN (3) CN102702319B (xx)
AU (1) AU2007218649B2 (xx)
BR (1) BRPI0708125A2 (xx)
CA (4) CA2886551A1 (xx)
CY (1) CY1113117T1 (xx)
DK (2) DK1988163T3 (xx)
ES (3) ES2387685T3 (xx)
HK (1) HK1125968A1 (xx)
IL (4) IL193026A (xx)
MX (1) MX2008010842A (xx)
MY (1) MY149527A (xx)
NO (1) NO20084008L (xx)
PH (1) PH12012502372B1 (xx)
PL (1) PL1988163T3 (xx)
PT (1) PT1988163E (xx)
RU (2) RU2435782C2 (xx)
SI (1) SI1988163T1 (xx)
WO (1) WO2007097358A1 (xx)
ZA (1) ZA200806542B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101522079B1 (ko) 2003-11-05 2015-05-21 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 Wt1 유래의 hla-dr 결합성 항원 펩티드
AU2006304573B2 (en) 2005-10-17 2012-05-24 Sloan Kettering Institute For Cancer Research WT1 HLA class II-binding peptides and compositions and methods comprising same
MX2008010842A (es) 2006-02-22 2008-09-01 Int Inst Cancer Immunology Inc Peptido de tumor de wilms restringido por antigeno leucocitario humano-a*3303 y composicion farmaceutica que comprenden el mismo.
EP3834836A1 (en) 2006-04-10 2021-06-16 Memorial Sloan Kettering Cancer Center Immunogenic wt-1 peptides and uses thereof
NZ578721A (en) 2007-02-27 2012-04-27 Int Inst Cancer Immunology Inc Method for activation of helper t cell and composition for use in the method
KR102079480B1 (ko) 2010-10-05 2020-02-19 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 헬퍼 t 세포의 활성화 방법
PE20141271A1 (es) 2011-04-01 2014-10-08 Sloan Kettering Inst Cancer Anticuerpos tipo receptor de celulas t especificos para un peptido wt1 presentado por hla-a2
CA2846479A1 (en) 2011-09-14 2013-03-21 International Institute Of Cancer Immunology, Inc. Method for measuring anti-wt1 antibody
AU2013207669C1 (en) 2012-01-13 2018-05-31 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
WO2014042226A1 (ja) 2012-09-12 2014-03-20 株式会社癌免疫研究所 抗原特異的ヘルパーt細胞レセプター遺伝子
MX364732B (es) 2012-12-13 2019-05-06 Univ Pennsylvania Vacuna contra el tumor de wilms 1.
MX2015007745A (es) 2012-12-17 2015-12-15 Otsuka Pharma Co Ltd Metodo para activar la celula t auxiliar.
PL2945647T3 (pl) 2013-01-15 2021-03-08 Memorial Sloan Kettering Cancer Center Immunogenne peptydy wt-1 i sposoby ich zastosowania
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
CA2840988A1 (en) 2013-02-05 2014-08-05 Nitto Denko Corporation Wt1 peptide cancer vaccine composition for mucosal administration
RU2687144C2 (ru) 2013-02-05 2019-05-07 Нитто Денко Корпорейшн Композиция противораковой вакцины, содержащей пептид wt1, для трансдермального введения
RU2014102939A (ru) 2013-02-05 2015-08-10 Нитто Денко Корпорейшн Вакцинная композиция для чрескожного введения
CA2840974A1 (en) 2013-02-05 2014-08-05 Nitto Denko Corporation Vaccine composition for mucosal administration
KR20140100420A (ko) 2013-02-05 2014-08-14 닛토덴코 가부시키가이샤 경피 또는 점막 투여용 백신 조성물
US10071051B2 (en) 2013-02-05 2018-09-11 Nitto Denko Corporation WT1 peptide cancer vaccine composition for transdermal administration
US10076491B2 (en) 2013-02-05 2018-09-18 Nitto Denko Corporation Vaccine composition
CA2841014A1 (en) 2013-02-05 2014-08-05 Nitto Denko Corporation Tape preparation of wt1 peptide cancer vaccine for transdermal administration
CA2970236A1 (en) 2014-12-11 2016-06-16 International Institute Of Cancer Immunology, Inc. Compositions comprising wt1 peptide for immunotherapy of angiogenic disease
WO2016104486A1 (ja) 2014-12-25 2016-06-30 国立大学法人大阪大学 T細胞集団の改変方法
JP2018513128A (ja) 2015-03-20 2018-05-24 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Isg15及びアジュバントとしてのその使用
US10899790B2 (en) 2016-11-09 2021-01-26 Osaka University Method for modifying T cell population

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69033127T2 (de) 1989-11-13 1999-10-14 Massachusetts Institute Of Technology Lokalisation und charakterisierung des wilms-tumor-gens
US5595756A (en) 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
US6270777B1 (en) * 1996-12-20 2001-08-07 University Technologies International Inc. Conserved metalloprotease epitopes
GB9805877D0 (en) * 1998-03-20 1998-05-13 Imp Cancer Res Tech Cancer
PL201881B1 (pl) 1998-09-30 2009-05-29 Corixa Corp Izolowany polipeptyd składający się z immunogennej części natywnego WT1, zawierająca go kompozycja farmaceutyczna i szczepionka oraz polinukleotyd kodujący ten polipeptyd
US20030072767A1 (en) 1998-09-30 2003-04-17 Alexander Gaiger Compositions and methods for WT1 specific immunotherapy
US7655249B2 (en) 1998-09-30 2010-02-02 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US20030039635A1 (en) 1998-09-30 2003-02-27 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US20030235557A1 (en) * 1998-09-30 2003-12-25 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US7144581B2 (en) 2000-10-09 2006-12-05 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US7115272B1 (en) 1998-09-30 2006-10-03 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US7901693B2 (en) 1998-09-30 2011-03-08 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US7063854B1 (en) 1998-09-30 2006-06-20 Corixa Corporation Composition and methods for WTI specific immunotherapy
AU7859900A (en) 1999-10-04 2001-05-10 Corixa Corporation Compositions and methods for wt1 specific immunotherapy
US6797695B1 (en) * 1999-10-22 2004-09-28 Kyoto University Human FGF-20 gene and gene expression products
AU2001285018A1 (en) 2000-08-17 2002-02-25 Agensys, Inc. Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer
CA2440303C (en) * 2001-03-22 2013-03-19 Haruo Sugiyama Wt1 modified peptide
US20040197892A1 (en) * 2001-04-04 2004-10-07 Michael Moore Composition binding polypeptides
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
KR101050703B1 (ko) 2002-06-12 2011-07-20 추가이 세이야쿠 가부시키가이샤 Hla-a24-구속성 암 항원 펩티드
AU2003262094A1 (en) 2002-09-12 2004-04-30 Haruo Sugiyama Cancer antigen peptide preparation
DE602004023476D1 (de) * 2003-01-15 2009-11-19 Chugai Pharmaceutical Co Ltd Dimerisiertes peptid
CA2514058C (en) * 2003-01-24 2014-05-13 Agensys, Inc. Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
US6980709B2 (en) 2003-06-20 2005-12-27 Northrop Grumman Corporation Polymeric material with voids that compress to allow the polymeric material to absorb applied force and decrease reaction force to one or more sensor fibers
DK2186896T3 (en) * 2004-03-31 2015-12-21 Int Inst Cancer Immunology Inc Cancer antigen peptides derived from WT1
MX2008010842A (es) 2006-02-22 2008-09-01 Int Inst Cancer Immunology Inc Peptido de tumor de wilms restringido por antigeno leucocitario humano-a*3303 y composicion farmaceutica que comprenden el mismo.

Also Published As

Publication number Publication date
WO2007097358A1 (ja) 2007-08-30
EP2385117B1 (en) 2016-07-27
CY1113117T1 (el) 2016-04-13
PT1988163E (pt) 2012-08-28
DK2518149T3 (en) 2016-01-11
EP1988163A4 (en) 2010-03-17
PH12012502372A1 (en) 2016-04-04
IL218172A0 (en) 2012-03-29
US8778350B2 (en) 2014-07-15
PH12012502372B1 (en) 2016-04-04
SI1988163T1 (sl) 2012-09-28
EP2518149A1 (en) 2012-10-31
US8945578B2 (en) 2015-02-03
IL193026A (en) 2015-09-24
US20140193442A1 (en) 2014-07-10
KR20080097203A (ko) 2008-11-04
CN102702319B (zh) 2015-01-28
ES2558330T3 (es) 2016-02-03
BRPI0708125A2 (pt) 2011-05-17
IL193026A0 (en) 2009-02-11
US20140199332A1 (en) 2014-07-17
RU2008137635A (ru) 2010-03-27
US8933038B2 (en) 2015-01-13
IL232409A0 (en) 2014-06-30
EP2518149B1 (en) 2015-12-16
CN102702319A (zh) 2012-10-03
DK1988163T3 (da) 2012-08-20
US8759483B2 (en) 2014-06-24
CA2886551A1 (en) 2007-08-30
CA2886615A1 (en) 2007-08-30
ES2387685T3 (es) 2012-09-28
MY149527A (en) 2013-09-13
AU2007218649A1 (en) 2007-08-30
RU2011132212A (ru) 2013-02-10
CA2886552A1 (en) 2007-08-30
CN102250211A (zh) 2011-11-23
KR101391561B1 (ko) 2014-05-02
EP2385117A1 (en) 2011-11-09
ES2587980T3 (es) 2016-10-28
US8968745B2 (en) 2015-03-03
EP1988163A1 (en) 2008-11-05
ZA200806542B (en) 2009-07-29
IL232408A0 (en) 2014-06-30
US20100292160A1 (en) 2010-11-18
CA2638122A1 (en) 2007-08-30
CN101384716B (zh) 2013-03-13
MX2008010842A (es) 2008-09-01
JP5393144B2 (ja) 2014-01-22
CN101384716A (zh) 2009-03-11
US20120195918A1 (en) 2012-08-02
EP1988163B1 (en) 2012-06-27
RU2435782C2 (ru) 2011-12-10
PL1988163T3 (pl) 2012-11-30
NO20084008L (no) 2008-11-24
JPWO2007097358A1 (ja) 2009-07-16
US20140193443A1 (en) 2014-07-10
AU2007218649B2 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
BRMU8603216U8 (xx)
BRPI0708307B8 (xx)
CH2121272H1 (xx)
BY9789C1 (xx)
CN300725922S (zh) 童装(3773)
CN300725934S (zh) 童装(3833)
CN300725927S (zh) 童装(3795)
CN300732497S (zh) 汽车
CN300731050S (zh) 拖鞋(3650)
CN300725926S (zh) 童装(3793)
CN300725925S (zh) 童装(3791)
CN300729936S (zh) 三芯硅橡胶冷缩指套
CN300725924S (zh) 童装(3789)
CN300729420S (zh) 食品罐
CN300728698S (zh) 纱罗布(t-173)
CN300728586S (zh) 拖鞋(3236)
CN300728384S (zh) 灯(e27-e26-par20-led)
CN300728338S (zh) 门(12)
CN300728054S (zh) 玩具(25)
CN300728053S (zh) 玩具(24)
CN300726856S (zh) 包装盒(通窍鼻炎片·黄)
CN300727200S (zh) 时钟(ar1646)
CN300727125S (zh) 包装袋(金地杰酸辣脆瓜)
CN300727029S (zh) 铅笔包装袋(196)
CN300725932S (zh) 童装(3829)